Colin John Meyer Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Colin John Meyer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Colin John Meyer. Colin John Meyer is Chief Medical Officer in REATA PHARMACEUTICALS INC ($RETA) and Chief Research Officer in REATA PHARMACEUTICALS INC ($RETA) and See Remarks in REATA PHARMACEUTICALS INC ($RETA).
Latest Insider Trading Transactions of Colin John Meyer
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Option Exercise | C | 0.00 | 6,395 | 0 | 59,779 | |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Option Exercise | M | 0.00 | 6,395 | 0 | 66,174 | |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Option Exercise | M | 11.00 | 6,395 | 70,345 | 88,636 | |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Option Exercise | C | 0.00 | 18,605 | 0 | 59,779 | |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Option Exercise | M | 0.00 | 18,605 | 0 | 78,384 | |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Option Exercise | M | 11.00 | 18,605 | 204,655 | 95,031 | |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 170.59 | 200 | 34,118 | 72,000 | 72.2 K to 72 K (-0.28 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 166.14 | 1,930 | 320,643 | 72,200 | 74.1 K to 72.2 K (-2.60 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 165.25 | 1,815 | 299,922 | 74,130 | 75.9 K to 74.1 K (-2.39 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 164.44 | 2,450 | 402,888 | 75,945 | 78.4 K to 75.9 K (-3.13 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Buy | C | 0.00 | 6,395 | 0 | 78,395 | 72 K to 78.4 K (+8.88 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 175.00 | 100 | 17,500 | 72,000 | 72.1 K to 72 K (-0.14 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 174.98 | 200 | 34,996 | 72,100 | 72.3 K to 72.1 K (-0.28 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 173.75 | 100 | 17,375 | 72,300 | 72.4 K to 72.3 K (-0.14 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 172.61 | 2,207 | 380,943 | 72,400 | 74.6 K to 72.4 K (-2.96 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 171.38 | 3,824 | 655,367 | 74,607 | 78.4 K to 74.6 K (-4.88 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 170.48 | 12,174 | 2,075,397 | 78,431 | 90.6 K to 78.4 K (-13.44 %) |
Nov 18 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Buy | C | 0.00 | 18,605 | 0 | 90,605 | 72 K to 90.6 K (+25.84 %) |
Nov 10 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Research Offi ... | Sell | S | 175.00 | 25,000 | 4,375,000 | 72,000 | 97 K to 72 K (-25.77 %) |
Jan 06 2020 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | A | 207.20 | 25,000 | 5,180,000 | 25,000 | |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | C | 0.00 | 69,828 | 0 | 59,779 | |
Dec 17 2019 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Buy | C | 0.00 | 69,828 | 0 | 97,000 | 27.2 K to 97 K (+256.99 %) |
Nov 12 2019 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | A | 55.73 | 17,750 | 989,208 | 17,750 | |
Nov 12 2019 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | A | 55.73 | 17,750 | 989,208 | 17,750 | |
Jan 29 2019 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | M | 0.00 | 622 | 0 | 129,607 | |
Jan 29 2019 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | M | 8.11 | 622 | 5,044 | 0 | |
Jan 03 2019 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | A | 55.73 | 35,500 | 1,978,415 | 35,500 | |
Dec 13 2017 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | M | 11.62 | 11,822 | 137,372 | 19,525 | |
Dec 13 2017 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | M | 8.11 | 827 | 6,707 | 622 | |
Dec 13 2017 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | M | 7.86 | 2,351 | 18,479 | 0 | |
Dec 13 2017 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | M | 0.00 | 11,822 | 0 | 128,985 | |
Dec 13 2017 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | M | 0.00 | 827 | 0 | 117,163 | |
Dec 13 2017 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | M | 0.00 | 2,351 | 0 | 116,336 | |
Dec 07 2017 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | A | 24.75 | 87,700 | 2,170,575 | 87,700 | |
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | A | 22.57 | 90,000 | 2,031,300 | 90,000 | |
Aug 17 2016 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Buy | P | 16.26 | 7,000 | 113,820 | 27,172 | 20.2 K to 27.2 K (+34.70 %) |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | See Remarks | Option Exercise | C | 0.00 | 10,172 | 0 | 113,985 | |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | See Remarks | Buy | P | 11.00 | 10,000 | 110,000 | 20,172 | 10.2 K to 20.2 K (+98.31 %) |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | See Remarks | Buy | C | 0.00 | 10,172 | 0 | 10,172 | 0 to 10.2 K |
May 26 2016 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | See Remarks | Option Exercise | A | 11.00 | 113,636 | 1,249,996 | 113,636 |
Page: 1